Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report
Main Authors: | Rauf, Mariam, Gleason, Charise, Nooka, Ajay K, Husman, Abbie, Waller, Edmund K |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169495/ |
Similar Items
-
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
by: Nooka, Ajay, et al.
Published: (2013) -
From Single Nucleotide Polymorphisms to Constant Immunosuppression: Mesenchymal Stem Cell Therapy for Autoimmune Diseases
by: Chinnadurai, Raghavan, et al.
Published: (2013) -
A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications
by: Corrie, P G, et al.
Published: (2012) -
Graft-versus-host Reactions in the Rabbit
by: Porter, K. A.
Published: (1960) -
Oral pyridoxine can substitute for intravenous pyridoxine in managing patients with severe poisoning with isoniazid and rifampicin fixed dose combination tablets: a case report
by: M. D. S. A. Dilrukshi, et al.
Published: (2017-08-01)